Table 1.
Comparison between Pancreatic and Nonpancreatic Diabetes Mellitus Groups
| Pancreatic DM (n=47) | Nonpancreatic DM (n=90)* | p-value | |
|---|---|---|---|
| Backgrounds | |||
| Age, yr | 63.6±9.37 | 61.7±12.6 | 0.297 |
| Sex, male/female | 41/6 | 71/19 | 0.333 |
| Follow-up period, mo | 77±42 | 69±42 | 0.339 |
| Cause of CP, alcoholic/nonalcoholic | 37/10 | 63/27 | 0.275 |
| Pancreatic calcification | 44/3 | 78/12 | 0.262 |
| Hemoglobin A1c, % (normal range, 4.6–6.2) | 6.9±0.90 | 5.9±0.47 | <0.001 |
| Administered drug | |||
| Pancreatic enzyme drug, +/− | 12/35 | 26/64 | 0.677 |
| Camostat mesilate, +/− | 14/33 | 28/62 | 0.873 |
| Antihyperlipidemic agents, +/− | 12/35 | 15/75 | 0.216 |
| Neutritional marker | |||
| BMI, kg/m2 | 21.7±2.72 | 21.2±2.93 | 0.341 |
| Albumin, g/dL (range, 3.9–4.9) | 4.06±0.284 | 4.14±0.331 | 0.166 |
| Prealbumin, mg/dL (range, 19–24) | 26.1±6.70 | 26.5±6.12 | 0.705 |
| Total cholesterol, mg/dL (range, 129–232) | 164±30.0 | 183±36.6 | 0.003 |
| Cholinesterase, U/L (range, 203–460) | 263±68.9 | 291±60.0 | 0.016 |
| Magnesium, mg/dL (range, 1.6–2.4) | 2.01±0.213 (n=43) | 2.05±0.198 (n=77) | 0.381 |
| Hemoglobin, g/dL (range, 13.8–16.6) | 13.5±1.58 | 13.5±1.57 | 0.940 |
Data are presented as mean±SD or number.
DM, diabetes mellitus; CP, chronic pancreatitis; BMI, body mass index.
*
86 patients without DM+3 patients with type 2 DM+1 patient with steroid-induced DM.